Sparta Systems and Spain Based TDV Announce Partnership to Provide In Country TrackWise Support
Collaboration set to provide implementation and validation services to the Spanish market
Hamilton, NJ Mar 22, 2013 – Sparta Systems, Inc., a market leader in enterprise quality management software (EQMS) solutions, today announced a partnership with TDV, a Spanish technological consulting company providing services to the Pharmaceutical and API Industry, to provide local implementation and validation services.
“The strategic partnership with TDV will allow Sparta to better support clients in Spain using TrackWise EQMS by providing on the ground, locally based, Spanish speaking resources to further the direct reach of TrackWise’s quality management support and services to the Spanish market ,” said Roy Wood, Vice President of Global Professional Services at Sparta Systems. “Life sciences companies are faced with the unique challenge of adhering to strict regulatory guidelines and requirements, while needing business partners that have a deep level of understanding and experience in their industry.”
Sparta Systems and TDV both have a proven track record of successfully supporting companies within the life sciences industry. The collaboration enables TDV to benefit from Sparta’s market leadership to extend its implementation services and provide customers with a reliable, robust EQMS. TDV currently provides validation, compliance and quality services to companies in Spain and the partnership will enable Sparta to expand its customer base and develop new and existing business relationships in the country.
“We are committed to providing customers with the best and most advanced services, and our partnership with Sparta Systems further supports our efforts,” said Octavi Colomina, Managing Director at TDV. “TrackWise serves as the de-facto solution for quality management support throughout the life sciences industry. The collaboration with Sparta will enable us to improve the line of services we provide our customers, specifically in relation to the development of pharmaceutical quality systems aligned within the guidelines set forth in ICH Q10.”